Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)
- PMID: 15464254
- DOI: 10.1016/j.jhep.2004.06.016
Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)
Similar articles
-
Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Liver Injury.Adv Exp Med Biol. 2019;1182:217-242. doi: 10.1007/978-981-32-9421-9_9. Adv Exp Med Biol. 2019. PMID: 31777021 Review.
-
Ganoderma lucidum: a cause of pseudoparasitosis.Southeast Asian J Trop Med Public Health. 2006 Nov;37(6):1099-102. Southeast Asian J Trop Med Public Health. 2006. PMID: 17333761
-
Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder.J Med Assoc Thai. 2007 Jan;90(1):179-81. J Med Assoc Thai. 2007. PMID: 17621752
-
Anticancer effects of Ganoderma lucidum: a review of scientific evidence.Nutr Cancer. 2005;53(1):11-7. doi: 10.1207/s15327914nc5301_2. Nutr Cancer. 2005. PMID: 16351502 Review.
-
Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)?Int J Surg Pathol. 2007 Apr;15(2):180-6. doi: 10.1177/1066896906295890. Int J Surg Pathol. 2007. PMID: 17478779
Cited by
-
Immunomodulatory dietary polysaccharides: a systematic review of the literature.Nutr J. 2010 Nov 18;9:54. doi: 10.1186/1475-2891-9-54. Nutr J. 2010. PMID: 21087484 Free PMC article. Review.
-
In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine.Front Pharmacol. 2019 May 3;10:458. doi: 10.3389/fphar.2019.00458. eCollection 2019. Front Pharmacol. 2019. PMID: 31130860 Free PMC article.
-
Herbal Supplement-Induced Liver Injury: A Case Report.Cureus. 2023 Jan 11;15(1):e33663. doi: 10.7759/cureus.33663. eCollection 2023 Jan. Cureus. 2023. PMID: 36819353 Free PMC article.
-
The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk.Pharm Biol. 2021 Dec;59(1):1161-1171. doi: 10.1080/13880209.2021.1969413. Pharm Biol. 2021. PMID: 34465259 Free PMC article. Review.
-
A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.Sci Rep. 2016 Aug 11;6:29540. doi: 10.1038/srep29540. Sci Rep. 2016. PMID: 27511742 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical